Evoke Pharma Inc (EVOK) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Evoke Pharma Inc (Evoke Pharma) is a pharmaceutical company that develops drugs to treat gastrointestinal diseases. The company offers Gimoti that provides predictable absorption and symptom relief during a flare regardless of gastric emptying delays and vomiting. It also offers solutions for nausea, bloating, upper abdominal pain, prolonged fullness, early satiety and vomiting. The company operates through other commercial organizations and external consultants to develop novel product candidates. It also develops programs with associated clinical data, products containing previously approved compounds, and others. Evoke Pharma is headquartered in Solana Beach, California, the US.

Evoke Pharma Inc (EVOK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 5
List of Figures 5
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Evoke Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Evoke Pharma Inc, Medical Devices Deals, 2012 to YTD 2018 10
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Evoke Pharma Enters into Agreement with Thermo Fisher Scientific 12
Evoke Pharma Enters into Partnership with Spaulding Clinical Research 13
Equity Offering 14
Evoke Pharma Plans to Raise up to USD16 Million in Public Offering of Shares 14
Evoke Pharma Raises USD8 Million in Public Offering of Shares 15
Evoke Pharma Raises USD4.5 Million in Registered Direct Offering 16
Evoke Pharma to Raise USD10 Million in Registered Direct Offering 18
Evoke Pharma Raises USD5 Million in Public Offering of Shares 19
Evoke Pharma to Raise Funds through Public Offering of Shares 20
Evoke Pharma Completes Underwriters Exercise Of Full Over-Allotment Option Of IPO For US$29 Million 21
Evoke Pharma Inc - Key Competitors 23
Evoke Pharma Inc - Key Employees 24
Evoke Pharma Inc - Locations And Subsidiaries 25
Head Office 25
Recent Developments 26
Financial Announcements 26
Aug 09, 2018: Evoke Pharma reports second quarter 2018 results and recent highlights 26
May 14, 2018: Evoke Pharma Reports First Quarter 2018 Results and Highlights 27
Mar 07, 2018: Evoke Pharma Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Highlights 28
Nov 14, 2017: Evoke Pharma Reports Third Quarter 2017 Results and Highlights 29
Aug 14, 2017: Evoke Pharma Reports Second Quarter 2017 Results and Highlights 30
May 15, 2017: Evoke Pharma Reports First Quarter 2017 Results 31
May 15, 2017: Evoke Pharma Q1 net loss increases 32
Mar 15, 2017: Evoke Pharma Reports Fourth Quarter and Full Year 2016 Results 33
Product News 34
10/27/2017: Evoke Pharma Announces Conference Call to Review the Successful Results of Comparative Exposure Pharmacokinetic Study for Gimoti 34
10/23/2017: Evoke Pharma Announces Positive Topline Results from Comparative Exposure Pharmacokinetic Study for Gimoti 35
10/04/2017: Evoke Pharma to Participate in the Oppenheimer & Co. Specialty Pharmaceuticals Conference 36
09/05/2017: Evoke Pharma to Present at the 19th Annual Rodman & Renshaw Global Investment Conference 37
05/15/2017: Evoke Pharma Provides Update on Gimoti 38
02/15/2018: Evoke Announces Discovery of Sex-Based Pharmacokinetic Differences for Gimoti 39
Product Approvals 40
Sep 12, 2017: Evoke Pharma Completes Dosing for Gimoti Comparative Exposure Pharmacokinetic Study 40
Aug 14, 2017: Evoke Pharma Initiates Comparative Exposure Pharmacokinetic Study for Gimoti 41
May 31, 2017: Evoke Pharma Enters Agreement with Rho to Submit NDA for Gimoti 42
Apr 04, 2017: Positive Type A Meeting with FDA Confirms Acceptability of Evoke Pharmas Proposed Comparative Exposure PK Trial for Gimoti NDA 43
Feb 15, 2017: FDA Exempts Evoke from Requirement for Human Factor Validation Study 44
Clinical Trials 45
May 10, 2017: Evoke Pharma Presents Gimoti Efficacy and Safety Data from Phase 3 Trial as Late Breaker at Digestive Disease Week 2017 45
Mar 21, 2017: Evoke Pharmas Phase 3 Results for Gimoti Accepted as Late-Breaker for Presentation at Digestive Disease Week 2017 46
Jan 09, 2017: Evoke Pharma to Attend 2017 JPMorgan Healthcare Conference 47
Jan 04, 2017: Evoke Provides Additional Data Demonstrating Statistically Significant Benefit for Gimoti in Moderate to Severe Patients in Phase 3 Diabetic Gastroparesis Trial 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List Of Tables


Evoke Pharma Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Evoke Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Evoke Pharma Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Evoke Pharma Inc, Medical Devices Deals, 2012 to YTD 2018 10
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Evoke Pharma Enters into Agreement with Thermo Fisher Scientific 12
Evoke Pharma Enters into Partnership with Spaulding Clinical Research 13
Evoke Pharma Plans to Raise up to USD16 Million in Public Offering of Shares 14
Evoke Pharma Raises USD8 Million in Public Offering of Shares 15
Evoke Pharma Raises USD4.5 Million in Registered Direct Offering 16
Evoke Pharma to Raise USD10 Million in Registered Direct Offering 18
Evoke Pharma Raises USD5 Million in Public Offering of Shares 19
Evoke Pharma to Raise Funds through Public Offering of Shares 20
Evoke Pharma Completes Underwriters Exercise Of Full Over-Allotment Option Of IPO For US$29 Million 21
Evoke Pharma Inc, Key Competitors 23
Evoke Pharma Inc, Key Employees 24

List Of Figures


Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Evoke Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Evoke Pharma Inc, Medical Devices Deals, 2012 to YTD 2018 10

Evoke Pharma Inc (EVOK) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Evoke Pharma Inc (Evoke Pharma) is a pharmaceutical company that develops drugs to treat gastrointestinal diseases. The company offers Gimoti that provides predictable absorption and symptom relief during a flare

USD 250 View Report

Evoke Pharma Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Evoke Pharma Inc Company Profile is a detailed strategic and analytical report on Evoke Pharma Inc. The 2018 version of the report offers detailed insights into the companys strategies, developments,

USD 200 View Report

Avisa Pharma Inc - Product Pipeline Analysis, 2019 Update

Avisa Pharma Inc (Avisa Pharma) is a medical device company that develops breath tests system for the diagnosis of pulmonary infections. The company provides product such as avisa breath test

USD 750 View Report

Lumos Pharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Lumos Pharma Inc (Lumos Pharma) is a developer of novel therapies for the treatment of rare and neglected diseases. The companys pipeline product includes LUM-001, LUM-201 and LUM-301. Its lead

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available